NCT03627312

Brief Summary

The study aims to examine the effects of providing omega-3 supplements on young offenders' antisocial behaviour. Participants will be randomized into three groups: (1) Omega-3, (2) Placebo and (3) Treatment as Usual. Self report and correctional officer ratings of behaviour will be assessed at 0 months (baseline), 3 months (end of supplementation), 6 months and 12 months. The investigators hypothesize that omega-3 supplementation will reduce antisocial behaviour among the young offenders.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
181

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Mar 2011

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2013

Completed
5 years until next milestone

First Submitted

Initial submission to the registry

July 31, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 13, 2018

Completed
Last Updated

August 13, 2018

Status Verified

August 1, 2018

Enrollment Period

2.4 years

First QC Date

July 31, 2018

Last Update Submit

August 9, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in Antisocial Behaviour (Aggression) at 3 months, 6 months and 12 months

    Proactive and Reactive Aggression Questionnaire (23 items). Scale of 0 (Never), 1 (Sometimes) and 2 (Often). Total range: 0 (min) to 46 (max). Higher scores indicate higher levels of aggression. 2 subscales: proactive aggression (range: 0 to 22) and reactive aggression (range: 0 to 22). Total and subscale scores computed by summing up the respective items.

    0 Months (baseline), 3 Months, 6 Months, 12 Months

  • Change in Antisocial Behaviour (Conduct and Oppositional Defiance) at 3 months, 6 months and 12 months

    Conduct and Oppositional Defiant Disorder Questionnaire (20 items). Scale of 0 (Never), 1 (Sometimes) and 2 (Often). Total range: 0 (min) to 40 (max). Higher scores indicate higher levels of Oppositional Defiant Disorder, Conduct Disorder and antisocial behaviour. 2 subscales: Oppositional Defiant Disorder (range: 0 to 16),Conduct Disorder (range: 0 to 24). Total and subscale scores are computed by summing up the respective items.

    0 Months (baseline), 3 Months, 6 Months, 12 Months

Secondary Outcomes (1)

  • Schizotypal Personality

    0 Months (baseline), 3 Months, 6 Months, 12 Months

Study Arms (3)

Omega-3

EXPERIMENTAL

this group receives a fruit juice drink containing omega-3

Combination Product: Omega-3Other: Treatment as Usual

Placebo

PLACEBO COMPARATOR

this group receives the same fruit juice drink as in the experimental group, but it does not contain omega-3

Combination Product: PlaceboOther: Treatment as Usual

Treatment as Usual

OTHER

this group do not receive a fruit juice drink

Other: Treatment as Usual

Interventions

Omega-3COMBINATION_PRODUCT

1g of omega-3 supplement to be taken per day for a duration of 3 months in the form of a fruit juice drink

Omega-3
PlaceboCOMBINATION_PRODUCT

Fruit juice drink only

Placebo

Young Offenders Intervention Programme

Omega-3PlaceboTreatment as Usual

Eligibility Criteria

Age16 Years - 21 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Admission into young offender's institution

You may not qualify if:

  • Allergy to fish and fish products
  • Serious mental illness and intellectual disability
  • Ability to read and write at the level required to complete self report questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Antisocial Personality Disorder

Interventions

Docosahexaenoic AcidsTherapeutics

Condition Hierarchy (Ancestors)

Personality DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Fatty Acids, Omega-3Dietary Fats, UnsaturatedDietary FatsFatsLipidsFatty Acids, UnsaturatedFatty AcidsFish OilsOils

Study Officials

  • Adrian Raine

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 31, 2018

First Posted

August 13, 2018

Study Start

March 1, 2011

Primary Completion

July 31, 2013

Study Completion

July 31, 2013

Last Updated

August 13, 2018

Record last verified: 2018-08